TRB Chemedica is a medium-sized Swiss pharmaceutical company, with a focus on research, development and marketing of innovative niche products in specific therapeutic areas, including rheumatology, ophthalmology and neurology. The company markets a range of ethical pharmaceuticals and medical devices, most of which are patented, in more than 40 countries worldwide.
TRB Chemedica is a growing organisation currently employing more than 500 people worldwide. The international headquarters are located in Geneva, Switzerland, with subsidiaries in Argentina, Austria, Brazil, France, Germany, Hong Kong, Hungary, Malaysia, Mexico, Poland, Singapore, Switzerland, Thailand and the United Kingdom. The company's plan for the future is to increase the in-house manufacturing capacity, continue to develop the subsidiaries, and extend the distribution network to cover more countries around the world. TRB Chemedica is committed to growth in the international arena.